Table of Contents Show
Mumbai based medtech startup Bioscan Research has closed a $1 million seed funding round led by Unicorn India Ventures, the company announced this week. The investment will support the startup’s efforts to expand its market presence, secure additional regulatory approvals, and enhance its flagship diagnostic device, CEREBO, which is designed to detect traumatic brain injuries before symptoms become visible.
A Closer Look at the Technology
Founded in 2017 by Anupam Lavania and Shilpa Malik, Bioscan Research develops non-invasive medical devices aimed at early brain injury detection. CEREBO combines near infrared spectroscopy (NIRS) with machine learning to identify intracranial injuries, giving healthcare providers a diagnostic tool that operates within the critical early treatment window—a period often considered decisive for patient outcomes in trauma care.
Why This Funding Matters
Traumatic brain injuries are notoriously difficult to diagnose quickly, particularly in emergency settings where imaging equipment may be unavailable or time-constrained. A portable, non invasive screening tool addresses a genuine gap in point of care diagnostics. For healthcare professionals and hospital administrators, technologies like CEREBO reflect a broader industry shift toward AI-assisted diagnostic tools.
The backing from Unicorn India Ventures, a firm focused on deeptech sectors including AI infrastructure and medical diagnostics since 2016, also reflects growing investor confidence in India’s homegrown medtech innovation.
Growth Trajectory
Bioscan Research reports 5x growth over the past 12 months and aims to triple that growth over the coming year, with plans to expand both domestically and into international markets.
What’s Next
With fresh capital secured, Bioscan Research is positioned to scale operations, pursue further regulatory clearances, and pursue overseas expansion. As adoption grows, the company’s trajectory will offer a useful case study in how India’s deeptech medical innovation sector matures over the next few years.
How CEREBO Works: A Quick Guide
What is CEREBO?
CEREBO is a non-invasive medical device that uses near infrared spectroscopy (NIRS) combined with machine learning algorithms to detect intracranial injuries.
How does it detect brain injuries?
NIRS technology measures light absorption patterns in brain tissue to identify abnormalities associated with traumatic brain injury. Machine learning models then analyze this data to flag potential injuries—often before visible symptoms emerge.
Who uses it?
Healthcare providers use CEREBO during initial patient assessments, particularly in emergency and trauma care settings, to support faster diagnostic decisions.
Why does early detection matter?
Identifying brain injuries within the critical treatment window can significantly influence patient recovery outcomes.
Also Read: Heatronics Secures Rs 1.8 Crore in Seed Funding Round Led by Inflection Point Ventures
